Breaking barriers in cancer treatment: Race Oncology pioneers a new era with bisantrene
Race Oncology (ASX:RAC) has announced positive results in killing cancer cells in combination with the drug bisantrene
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
MIC | Ann: MICH Fund Update - April 2024 | 13/05/24 | 0 | 63 | |||
|
|||||||
MIC | Ann: Appointment of Sophia Rahmani as Managing Director | 13/05/24 | 0 | 76 | |||
|
|||||||
MIC | Ann: Units on Issue & Monthly Redemptions - April 2024 | 07/05/24 | 0 | 65 | |||
|
|||||||
MIC | Ann: Quarterly Portfolio Disclosure - 31 March 2024 | 30/04/24 | 0 | 73 | |||
|
|||||||
MIC | Ann: MICH Fund Update - March 2024 | 16:52 | 0 | 79 | |||
|
|||||||
MIC | Ann: Units on Issue & Monthly Redemptions - March 2024 | 05/04/24 | 0 | 66 | |||
|
|||||||
MIC | Ann: MICH Fund Update - February 2024 | 13/03/24 | 0 | 93 | |||
|
|||||||
MIC | Ann: Units on Issue & Monthly Redemptions - February 2024 | 06/03/24 | 0 | 101 | |||
|
See All Discussions
Timeline
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
View More |